Nicole Lambert - Aug 3, 2021 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Director
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Stock symbol
RCUS
Transactions as of
Aug 3, 2021
Transactions value $
$0
Form type
4
Date filed
8/5/2021, 04:28 PM
Previous filing
Nov 1, 2021
Next filing
Aug 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Award $0 +4.7K $0.00 4.7K Aug 3, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCUS Stock Option (Right to Buy) Award $0 +21.7K $0.00 21.7K Aug 3, 2021 Common Stock 21.7K $30.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units that vest in three equal annual installments on each of September 15, 2022, September 15, 2023, and September 15, 2024, subject to the Reporting Person's continued service to the Company.
F2 The option is exercisable in 36 equal monthly installments after August 3, 2021, subject to the Reporting Person's continued service to the Company.